Dear Editor, We would like to discuss on the report on “Zosteriform cutaneous leishmaniasis” [1] Ramot et al. reported that “dermoscopy has proven to be an accessible and easy tool to diagnose such atypical presentation of cutaneous leishmaniasis, and dermatologists in endemic areas should be familiar with its typical dermoscopic features” [1]. In fact, cutaneous leishmaniasis is an important t...

A 52-year-old male farm worker from Ceará state, northeast Brazil, presented with a 4-month history of skin lesions. Lesions appeared first on the face and legs, than spread across much of his body, including the genitalia, soles of feet, and scalp. He reported daily fevers for the first 2 weeks of illness. On examination the patient had 178 lesions of different sizes and aspects; ulcerated, cr...

Dermatological disorders are among the most prevalent manifestations of HIV infection/acquired immunodeficiency syndrome (AIDS). In this review, we aimed to characterize various dermatologic presentations HIV-infected patients with a detailed categorization mucocutaneous signs and symptoms, their etiopathogenic factors, clinical management. fact, cutaneous quite various, ranging from AIDS-speci...

Cutaneous leishmaniasis is a protozoan disease caused by leishmanias, which results in deformations of the skin. Cutaneous leishmaniasis is endemic in the southeastern parts of Turkey. Cutaneous leishmaniasis is the most common form and is often observed in open regions of the body. Involvement of the penis was rarely reported. In this paper, we present a case of a giant hyperkeratotic form of ...

abstract background glucantime is the first line agent for treatment of cutaneous leishmaniasis (cl). it has adverse effects on blood elements. this research has been done to evaluate the blood complications of this medicine in patients with cutaneous leishmaniasis. methods this clinical trial was done at nikpour clinic, yazd, iran. blood samples were collected from patients diagnosed with cl b...

background: cutaneous leishmaniasis is an endemic disease in many regions of iran, including the city of mashhad. in recent years, some cases have not responded to glucantime, the usual treatment for this disease. the cellular immune response caused by t-helper type 1 (th1) cells has an important role in protection against leishmaniasis, and activation of the t-helper type 2 (th2) response caus...

a clinical and epidemiological comparison of the cutaneous leishmaniasis was carried out among 100 victims of cutaneous leishmaniasis who were living in the villages of isfahan area, and 100 other patients of the lesions have been determined and analyzed. comparison of patients of the city with that of neighboring villages shows that both type of cutaneous leishmaniasis are prevalent in isfahan...

69-year-old male patient, with history of multiple furunles for two months, without improvement after the use of ephalexin and amoxicillin/clavulanate for 20 days, and daily ever for a week. On dermatological examination, multiple lcerovegetative and ulcero-crusted cutaneous lesions on the ace, ears, scalp, back, upper and lower limbs and genitalia ere observed (Figs. 1 and 2). There was no lym...

More than 90% of patients infected with cutaneous leishmaniasis live in Afghanistan, the Middle East, Algeria, Brazil, and Peru. Cutaneous leishmaniasis in Iran is caused by Leishmania tropica and Leishmania major. Most skin lesions evolve from papular to nodular, to ulcerative form with a central depression surrounded by a raised indurate border. Some lesions persist as nodules or plaques. Mul...

background: leishmaniasis, especially cutaneous leishmaniasis, is considered an important health problem in many parts of iran including kharve, khorasan razavi province. cutaneous leishmaniasis is caused by various species of leishmania, each having a different secondary host. thus, identifying the parasites’ specie is of paramount importance for containment strategy planning. the morphologica...